抑制15-PGDH可以增强在衰老期间的造血再生
Rahul Chaudhary1, Brittany A Cordova1, Marcus Hong1
1Department of Medicine, and Case Comprehensive Cancer Center Case Western Reserve University, Cleveland, OH, USA.
Stem cells (Dayton, Ohio)
|July 3, 2025
概括
在老年小鼠中,抑制前列腺素降解酶15-基前列腺素脱酶 (15-PGDH) 能够使血造干细胞 (HSC) 复原. 这种干预增强了干细胞的功能,改善了血液的产生,为与年龄有关的造血衰退提供了潜在的治疗方法.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 衰老研究研究 衰老研究
背景情况:
- 造血衰老导致干细胞功能减弱和血液疾病增加.
- 之前已经确定15-hydroxyprostaglandin脱酶 (15-PGDH) 是血液造血干细胞活动的调节剂.
研究的目的:
- 研究15-PGDH在老化造血干细胞中的作用.
- 评估15-PGDH抑制 (PGDHi) 在缓解与年龄相关的造血衰退方面的治疗潜力.
主要方法:
- 在老鼠骨髓和脏中评估了15-PGDH的表达和活性.
- 对老年小鼠和分析的造血干细胞和原生细胞种群进行了长时间的PGDHi.
- 评估了PGDHi对老年小鼠移植后的造血复苏的影响.
- 评估了血液发育移植模型中的竞争优势和对髓质偏差的影响.
主要成果:
- 在老年小鼠中,15-PGDH的表达和活性保持不变,这表明其具有治疗意义.
- PGDHi显著增加了造血干细胞和祖细胞的频率和数量,具有功能增强的转录特征.
- PGDHi治疗改善了短期的造血复苏,周围血液输出和移植后的多血统复合.
- 在初级移植中,PGDHi赋予了竞争优势,并在二次移植中减少了与年龄相关的骨髓偏差,而不会影响稳定状态的血液生产.
结论:
- 抑制15-PGDH可以使衰老的造血干细胞 (HSC) 恢复青春.
- 在再生条件下,PGDHi增强了血液形成,同时保持了平衡.
- PGDHi代表了一种可翻译的干预措施,用于对抗与年龄相关的造血功能障碍.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
01:19Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
01:21Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
01:28Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
01:20Overview of Hematopoiesis
4.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.8K